Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine

被引:7
作者
Geeraedts, Felix
ter Veer, Wouter
Wilschut, Jan
Huckriede, Anke
de Haan, Aalzen [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, NL-9700 RB Groningen, Netherlands
关键词
Influenza; Whole inactivated virus vaccine; Fusion; IFNalpha; Th1; IMMUNE-RESPONSES; RECOGNITION; TLR7; CELLS; INFECTION; SUPERIOR; AFFINITY; INFANTS; ORIGIN; ASSAY;
D O I
10.1016/j.vaccine.2012.07.036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Whole inactivated virus (WIV) influenza vaccines are more immunogenic in unprimed individuals than split-virus or subunit vaccines. In mice, this superior immunogenicity has been linked to the recognition of the viral ssRNA by endosomal TLR7 receptors in immune cells, leading to IFN alpha production and Th1-type antibody responses. Recent data suggest that viral membrane fusion in target cell endosomes is necessary for TLR7-mediated IFN alpha induction. If so, virus inactivation procedures that compromise the fusion activity of WIV vaccines, like formaldehyde (FA) treatment, could potentially harm vaccine efficacy. Therefore, we measured the effect of fusion inactivation of H5N1 WIV on TLR7 activation in vitro, and on antibody isotype responses in vivo. Fusion inactivation of WIV reduced, but did not block, TLR7-dependent IFN alpha induction in murine dendritic cells in vitro. In vivo, fusion-inactive WIV was as potent as fusion-active WIV in inducing total H5N1-specific serum IgG and IgG2c subtype antibodies in unprimed mice. Both vaccines induced only small amounts of IgG1. However, FA treatment of WIV did reduce the capacity of the vaccine to induce hemagglutination-inhibiting (HI) antibodies. This possibly relates to modification of epitopes that are targets for HI antibodies rather than to loss of fusion activity. Antibody affinity maturation was not negatively affected by fusion inactivation. In conclusion, fusion activity of H5N1 WIV does not play a major role in Th1-type antibody induction. Yet, to preserve the full immunogenicity of WIV, or possibly also other inactivated influenza vaccines, harsh treatment with formaldehyde should be avoided. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6501 / 6507
页数:7
相关论文
共 50 条
  • [1] Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines - A review and meta-analysis of the literature
    Beyer, WEP
    Palache, AM
    Osterhaus, ADME
    [J]. CLINICAL DRUG INVESTIGATION, 1998, 15 (01) : 1 - 12
  • [2] A RAPID AND SENSITIVE SUB-MICRO PHOSPHORUS DETERMINATION
    BOETTCHER, C
    PRIES, C
    VANGENT, CM
    [J]. ANALYTICA CHIMICA ACTA, 1961, 24 (02) : 203 - &
  • [3] Bridges CB., 2008, Vaccines, P259
  • [4] Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity
    Budimir, Natalija
    Huckriede, Anke
    Meijerhof, Tjarko
    Boon, Louis
    Gostick, Emma
    Price, David A.
    Wilschut, Jan
    de Haan, Aalzen
    [J]. PLOS ONE, 2012, 7 (01):
  • [5] The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes
    Budimir, Natalija
    Meijerhof, Tjarko
    Wilschut, Jan
    Huckriede, Anke
    de Haan, Aalzen
    [J]. VACCINE, 2010, 28 (52) : 8280 - 8287
  • [6] Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection
    Bungener, Laura
    Geeraedts, Felix
    Ter Veer, Wouter
    Medema, Jeroen
    Wilschut, Jan
    Huckriede, Anke
    [J]. VACCINE, 2008, 26 (19) : 2350 - 2359
  • [7] Emerging influenza
    de Wit, Emmie
    Fouchier, Ron A. M.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2008, 41 (01) : 1 - 6
  • [8] Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
    Diebold, SS
    Kaisho, T
    Hemmi, H
    Akira, S
    Sousa, CRE
    [J]. SCIENCE, 2004, 303 (5663) : 1529 - 1531
  • [9] FORMALDEHYDE TREATMENT OF PROTEINS CAN CONSTRAIN PRESENTATION TO T-CELLS BY LIMITING ANTIGEN-PROCESSING
    DITOMMASO, A
    DEMAGISTRIS, MT
    BUGNOLI, M
    MARSILI, I
    RAPPUOLI, R
    ABRIGNANI, S
    [J]. INFECTION AND IMMUNITY, 1994, 62 (05) : 1830 - 1834
  • [10] A clinical trial of a whole-virus H5N1 vaccine derived from cell culture
    Ehrlich, Hartmut J.
    Mueller, Markus
    Oh, Helen M. L.
    Tambyah, Paul A.
    Joukhadar, Christian
    Montomoli, Emanuele
    Fisher, Dale
    Berezuk, Greg
    Fritsch, Sandor
    Loew-Baselli, Alexandra
    Vartian, Nina
    Bobrovsky, Roman
    Pavlova, Borislava G.
    Poellabauer, Eva Maria
    Kistner, Otfried
    Barrett, P. Noel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24) : 2573 - 2584